These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

719 related articles for article (PubMed ID: 27218427)

  • 21. Role of nanotechnology in pharmaceutical product development.
    Devalapally H; Chakilam A; Amiji MM
    J Pharm Sci; 2007 Oct; 96(10):2547-65. PubMed ID: 17688284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimating drug solubility in the gastrointestinal tract.
    Dressman JB; Vertzoni M; Goumas K; Reppas C
    Adv Drug Deliv Rev; 2007 Jul; 59(7):591-602. PubMed ID: 17599644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of intestinal absorption and blood-brain barrier penetration by computational methods.
    Clark DE
    Comb Chem High Throughput Screen; 2001 Sep; 4(6):477-96. PubMed ID: 11562253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patches for improving gastrointestinal absorption: an overview.
    Teutonico D; Ponchel G
    Drug Discov Today; 2011 Nov; 16(21-22):991-7. PubMed ID: 21683153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Location, location, location: gastrointestinal delivery site and its impact on absorption.
    Connor A
    Ther Deliv; 2012 May; 3(5):575-8. PubMed ID: 22834401
    [No Abstract]   [Full Text] [Related]  

  • 26. In silico prediction of brain and CSF permeation of small molecules using PLS regression models.
    Bendels S; Kansy M; Wagner B; Huwyler J
    Eur J Med Chem; 2008 Aug; 43(8):1581-92. PubMed ID: 18206268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut Wall Metabolism. Application of Pre-Clinical Models for the Prediction of Human Drug Absorption and First-Pass Elimination.
    Jones CR; Hatley OJ; Ungell AL; Hilgendorf C; Peters SA; Rostami-Hodjegan A
    AAPS J; 2016 May; 18(3):589-604. PubMed ID: 26964996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new gastro-intestinal mathematical model to study drug bioavailability.
    Pompa M; Capocelli M; Piemonte V
    Med Eng Phys; 2019 Dec; 74():106-114. PubMed ID: 31564501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanocarriers protecting toward an intestinal pre-uptake metabolism.
    Suchaoin W; Bernkop-Schnürch A
    Nanomedicine (Lond); 2017 Feb; 12(3):255-269. PubMed ID: 28093952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
    Meanwell NA
    Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ADME evaluation in drug discovery. 3. Modeling blood-brain barrier partitioning using simple molecular descriptors.
    Hou TJ; Xu XJ
    J Chem Inf Comput Sci; 2003; 43(6):2137-52. PubMed ID: 14632466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Permeability diagnosis model in drug discovery: a diagnostic tool to identify the most influencing properties for gastrointestinal permeability.
    Wang J; Skolnik S
    Curr Top Med Chem; 2013; 13(11):1308-16. PubMed ID: 23675937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physicochemical property profile for brain permeability: comparative study by different approaches.
    Raevsky OA; Grigorev VY; Polianczyk DE; Sandakov GI; Solodova SL; Yarkov AV; Bachurin SO; Dearden JC
    J Drug Target; 2016 Aug; 24(7):655-62. PubMed ID: 26755431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computational prediction of plasma protein binding of cyclic peptides from small molecule experimental data using sparse modeling techniques.
    Tajimi T; Wakui N; Yanagisawa K; Yoshikawa Y; Ohue M; Akiyama Y
    BMC Bioinformatics; 2018 Dec; 19(Suppl 19):527. PubMed ID: 30598072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs.
    Bergström CA; Holm R; Jørgensen SA; Andersson SB; Artursson P; Beato S; Borde A; Box K; Brewster M; Dressman J; Feng KI; Halbert G; Kostewicz E; McAllister M; Muenster U; Thinnes J; Taylor R; Mullertz A
    Eur J Pharm Sci; 2014 Jun; 57():173-99. PubMed ID: 24215735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent developments of in silico predictions of intestinal absorption and oral bioavailability.
    Hou T; Li Y; Zhang W; Wang J
    Comb Chem High Throughput Screen; 2009 Jun; 12(5):497-506. PubMed ID: 19519329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analytical tools for the physicochemical profiling of drug candidates to predict absorption/distribution.
    Henchoz Y; Bard B; Guillarme D; Carrupt PA; Veuthey JL; Martel S
    Anal Bioanal Chem; 2009 Jun; 394(3):707-29. PubMed ID: 19184676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recent advances in drug dissolution/permeation synchronous evaluation technologies based on physiological characteristics of gastrointestinal tract].
    Li ZQ; He X; Liu CX
    Yao Xue Xue Bao; 2016 Oct; 51(10):1540-50. PubMed ID: 29932598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in computational prediction of drug absorption and permeability in drug discovery.
    Hou T; Wang J; Zhang W; Wang W; Xu X
    Curr Med Chem; 2006; 13(22):2653-67. PubMed ID: 17017917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fragment library design, synthesis and expansion: nurturing a synthesis and training platform.
    Ray PC; Kiczun M; Huggett M; Lim A; Prati F; Gilbert IH; Wyatt PG
    Drug Discov Today; 2017 Jan; 22(1):43-56. PubMed ID: 27793744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.